Saturday, June 4, PL7 - EASO Plenary Session: Pros and cons of the diagnosis of Food Addiction for tackling the obesity epidemic

Transcription

1 Saturday, June 4, :30-09:15 Plenary Lecture 08:30-09:15 PL7 - EASO Plenary Session: Pros and cons of the diagnosis of Food Addiction for tackling the obesity epidemic Chair: S Dickson (Sweden) F4+F5 HALL PL7.01: Pros and cons of the diagnosis of Food Addiction for tackling the obesity epidemic J Hebebrand (Germany) 08:30-09:15 PL8 - IFSO-EC Plenary Session: Plastic Surgery after massive weight loss G3 HALL Chairs: A Elander (Sweden), M Fried (Czech Republic) 08:30-09:05 PL8.01: Plastic Surgery after massive weight loss A Elander (Sweden) 09:05-09:15 PL8.02: Desire for body contouring surgery risk factor for weight regain? VM Montpellier (The Netherlands) 09:15-09:45 EOS 2016 Closing Ceremony Poster Award Presentations, 2017 Congress presentations F4+F5 HALL 09:45-11:15 Oral Sessions 09:45-11:15 RS28 - Joint Session: Mental health and behaviour after bariatric surgery F2 HALL Chairs: F Pattou (France), F Rasmussen (Sweden) 09:45-10:10 RS28.01: The Psychosocial Burden of Obesity D Sarwer (U.S.A) 10:10-10:35 RS28.02: Hedonic reward B Schultes (Switzerland) 10:35-11:00 RS28.03: Food palatability M Bueter (Switzerland) 11:00-11:15 Discussion 09:45-11:15 OS11 - Oral Session: Clinical management II G3 HALL Chairs: J Jordan (Germany), Dragan Micic (Serbia) OS11.01: Abstract withdrawn OS11.02: Biopsy-proven liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients M Luger (Austria)

2 OS11.03: Metabolic outcomes after an 8 weeks low-calorie-diet in overweight, prediabetic individuals: the role of gender in the PREVIEW study OS11.04: Differential expression of tumorogenesis-related genes in blood leukocytes of obese women with and without breast cancer OS11.05: Insulin/IGF-1 signalling in colon mucosa following diet-induced weight loss and its implications for colorectal tumorigenesis: the INTERCEPT study OS11.06: Fibrinolysis Shutdown in Morbid Obesity: Tissue Plasminogen Activator Resistance and the Effects of Bariatric Surgery OS11.07: Weight loss improves impaired muscle capillary recruitment in abdominally obese men: effects on metabolic insulin resistance OS11.08: Host-microbiota-environment interactions in calorie restriction: an integrative view of multi-dimensional data P Christensen (Denmark) A Crujeiras (Spain) G Campanella (UK) A Morton (U.S.A) Y H. Kusters (The Netherlands) M Dao (France) 09:45-11:15 OS12: Oral Session: Obesity and (cardio)metabolic risk G4 HALL I Bosaeus (Sweden), I Larsson (Sweden) OS12.01: The relative contributions of visceral fat and liver fat to insulin resistance and insulin secretion in men and women: the NEO study OS12.02: Phospholipid transfer protein (PLTP) and metabolic diseases OS12.03: Mechanisms regulating insulin response to intragastric glucose in nondiabetic obese and lean subjects OS12.04: Title: Ectopic fat and the phenotype of sarcopenic obesity in metabolically healthy and metabolically abnormal middle-aged women OS12.05: Chronic intermittent hypoxia impairs insulin sensitivity but improves whole-body glucose tolerance by activating skeletal muscle AMP-activated protein kinase in mice OS12.06: Restoring the circadian clock with melatonin can reduce thrombotic risk associated with obesity R Mutsert (The Netherlands) L Lebrun (France) A Gerspach (Switzerland) E Poggiogalle (Italy) B Guigas (The Netherlands) R King (UK) OS12.07: Abstact withdrawn OS12.08: Serum ceramides are linked to low microbiome richness and diabetes risk in overweight and obese subjects B Kayser (France)

3 09:45-11:15 Hot Topic Oral Session (EASO) F1 HALL Chair: S Dickson (Sweden) Looking for cues infant hunger and satiety during milk feeding Success and failure of the National Childhood Measurement Programme in England Three genetic loci involved in both variation of body mass index and anorexia nervosa risk Inhibitory control training for appetitive behaviour change: A metaanalytic investigation of mechanisms of action and moderators of effectiveness Protein malabsorption and increase in food intake after Mini Gastric Bypass but not after Roux-en-Y Gastric Bypass Liraglutide 3.0 mg reduced the risk of developing type 2 diabetes and decreased body weight in the SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled trial Netalie Shloim (UK) Sonia Saxena (UK) Anke Hinney (Germany) Andrew Jones (UK) Maude Le Gall (France) Luc Van Gaal (Belgium) 09:45-11:15 OS13 - IFSO-EC Session: Abstract Prize - voting session F3 HALL Chairs: R Peterli (Switzerland), R Batterham (UK) 09:45-09:55 OS13.05: Resting energy expenditure after Roux-en Y gastric bypass surgery B Schultes (Switzerland) 09:55-10:05 10:05-10:15 10:15-10:25 10:25-10:35 10:35-10:45 OS13.01: Long-Term Effects of Roux-en Y Gastric Bypass on Type 2 Diabetes Mellitus in Patients with Morbid Obesity OS13.02: Bleeding during laparoscopic gastric bypass as a risk factor for postoperative complications. A cohort study from the Scandinavian Obesity Surgery Registry OS13.03: Reduction of Short-term Morbidity in the Standardized Fully Stapled Laparoscopic Roux-en Y Gastric Bypass: A Single Centre Study on Patients OS13.04: Early effects on glycemic control in Sleeve Gastrectomy and Roux-en-Y Gastric Bypass patients with type-2 diabetes OS13.06: Antrum preservation seems to accelerate gastric emptying after laparoscopic sleeve gastrectomy without having effects on weight loss. BJ Nergård (Norway) E Stenberg (Sweden) G Uijtterhaegen (Belgium) V Wallenius (Sweden) M Garay Solà (Spain) 10:45-10:55 OS13.07: Five-year results after Vertical Sleeve Gastrectomy (VSG) for severe obesity TN Flølo (Norway)

4 10:55-11:05 OS13.08: Secondary hyperparathyroidism 2 years after proximal and distal gastric bypass a randomised controlled study M Svanevik (Norway) 11:15-11:45 Coffee Break/Commercial Exhibition 11:45-13:15 Association/Review/Workshop Sessions Merged Programme: EASO and IFSO-EC Sessions 11:45-13:15 RS29 - Review Session: Adipogenesis G3 HALL Chair: S Enerbäck (Sweden) 11:45-12:15 RS29.01: Adipogenesis and its role in metabolic disorders A Bouloumie (France) 12:15-12:45 RS29.02: How does the origin of adipocytes impact on metabolic health? C Dani (France) 12:45-13:00 RS29.03: ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansion D Bauters (Belgium) 13:00-13:15 RS29.04: Effects of omega-3 PUFAs on brown and beige adipocyte differentiation and activation T Lopez (Spain) 11:45-13:15 RS30 - Symposium: Physical activity and nutritional assessment in children. G4 HALL Chair: C-E Flodmark (Sweden), I Lissau (Sweden) 11:45-12:15 RS30.01: What is new and reliable? M Lof (Sweden) 12:15-12:30 RS30.02: Adolescents' communication of high calorie low nutrient food items in imagebased social media C Holmberg (Sweden) 12:30-12:45 RS30.03: School effects on sedentary behaviour in 5-6 year old children J Clarke (UK) 12:45-13:00 13:00-13:15 RS30.04: Perceived fussy eating in children at 14 months of age and subsequent use of maternal feeding practices at 2 years the NOURISH cohort RS30.05: Overweight children consume larger meals: data from the Diet and Nutrition Survey of Infants and Young Children (DNSIYC) R Byrne (Australia) H Syrad (UK) 11:45-13:15 RS31 - IFSO-EC Review Session: Long term side effects of bariatric surgery F4+F5 HALL Chairs: N Zundel (USA), B Eliasson (Sweden)

5 11:45-12:07 RS31.01: Meal related symptoms after gastric bypass - dumping syndrome and reactive hypoglycaemia A Laurenius (Sweden) 12:07-12:29 RS31.02: How to handle internal hernias UKsetting H Gislasson (Norway) 12:29-12:51 RS31.03: Abdominal pain after bariatric surgery A Maleckas (Lithuania) 12:51-13:13 RS31.04: Too much weight loss R Batterham (UK) 11:45-13:15 RS32 - Review Debate: Can we learn anything from Omics? F2 HALL Chair: M Ryden (Sweden) 11:45-12:15 RS32.01: Yes B van Ommen (The Netherlands) 12:15-12:45 RS32.02: No D Langin (France) 12:45-13:00 Discussion 13:15-14:45 Joint Closing Plenary Session 13:15-14:45 PL9 - Long term effects of bariatric surgery F4+F5 HALL Chairs: M Suter (Switzerland), I Näslund (Sweden) 13:15-13:35 PL9.01: Improvements in NAFLD F Pattou (France) 13:35-13:55 PL9.02: Effects on Depression Changes in Quality of Life, Body Image and Sexual Functioning D Sarwer (U.S.A.) 13:55-14:15 PL9.03: Bariatric surgery and hypertension J Jordan (Germany) 14:15-14:35 PL9.04: Kidney Diseases in Obesity and Bariatric Surgery G Mingrone (Italy)